AbstractApart from long-term central venous catheterisation, the insertion of an arteriovenous graft (AVG) remains the only option to allow continued haemodialysis when the patient's superficial veins have been exhausted. Although, expanded PTFE has become the graft of choice for haemodialysis access throughout the world, many other organic or semi-organic materials are currently available for AVG construction. These are less prone to steal syndrome, easier to handle, more resistant to infection and may have similar, if not better, long term patencies
Vascular access-related complications are still one of the leading causes of morbidity in hemodialys...
Cardiovascular disease is one of the major leading causes of death in today's world. Among the most ...
Current guidelines promote the use of native arteriovenous fistulas (AVF) as first choice access ove...
Apart from long-term central venous catheterisation, the insertion of an arteriovenous graft (AVG) r...
AbstractApart from long-term central venous catheterisation, the insertion of an arteriovenous graft...
In hemodialysis patients with insufficient vasculature for creation of a native arteriovenous fistul...
Vascular access (VA) serves as a lifeline for hemodialysis patients. Timely creation and meticulous ...
We report the results of 90 stretch polytetrafluoroethylene (PTFE) grafts in 78 chronic renal failur...
Prosthetic arteriovenous grafts (AVGs) are indicated for vascular access for long-term hemodialysis ...
The Thoratec (Vectra) polyurethane vascular access graft (TPVA) is among the most recent additions t...
Cryopreserved allografts have demonstrated resistance to infection similar to that of autogenous tis...
In hemodialysis, vascular access is a key issue. The preferred access is an arteriovenous fistula on...
As chronic kidney disease (CKD) progresses to the terminal stage, proper actions must be taken to pr...
arteriovenous graft, and a central double-lumen venous catheter. Our first choice for hemodialysis i...
In a preliminary study, 38 preserved human homologous saphenous vein grafts were used for secondary ...
Vascular access-related complications are still one of the leading causes of morbidity in hemodialys...
Cardiovascular disease is one of the major leading causes of death in today's world. Among the most ...
Current guidelines promote the use of native arteriovenous fistulas (AVF) as first choice access ove...
Apart from long-term central venous catheterisation, the insertion of an arteriovenous graft (AVG) r...
AbstractApart from long-term central venous catheterisation, the insertion of an arteriovenous graft...
In hemodialysis patients with insufficient vasculature for creation of a native arteriovenous fistul...
Vascular access (VA) serves as a lifeline for hemodialysis patients. Timely creation and meticulous ...
We report the results of 90 stretch polytetrafluoroethylene (PTFE) grafts in 78 chronic renal failur...
Prosthetic arteriovenous grafts (AVGs) are indicated for vascular access for long-term hemodialysis ...
The Thoratec (Vectra) polyurethane vascular access graft (TPVA) is among the most recent additions t...
Cryopreserved allografts have demonstrated resistance to infection similar to that of autogenous tis...
In hemodialysis, vascular access is a key issue. The preferred access is an arteriovenous fistula on...
As chronic kidney disease (CKD) progresses to the terminal stage, proper actions must be taken to pr...
arteriovenous graft, and a central double-lumen venous catheter. Our first choice for hemodialysis i...
In a preliminary study, 38 preserved human homologous saphenous vein grafts were used for secondary ...
Vascular access-related complications are still one of the leading causes of morbidity in hemodialys...
Cardiovascular disease is one of the major leading causes of death in today's world. Among the most ...
Current guidelines promote the use of native arteriovenous fistulas (AVF) as first choice access ove...